Skip to content

H.R. 1734 · 118th Congress (2023–2025)

TRANQ Research Act of 2023

This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other new psychoactive substances.

In particular, NIST must support

  • basic measurement science and research;
  • near-real time spectrometry capabilities (i.e., a technique for rapidly identifying the chemical composition of a substance);
  • strategies and voluntary best practices for handling, transporting, and analyzing such substances; and
  • collaboration with other government agencies, institutions of higher education, and the private sector to enhance relevant narcotic and opioid detection and analysis capabilities.

Additionally, the Government Accountability Office must conduct a study on the capabilities of the federal government to detect, identify, and otherwise respond to threats of new psychoactive substances, such as xylazine.

Show official title

To require coordinated National Institute of Standards and Technology science and research activities regarding illicit drugs containing xylazine, novel synthetic opioids, and other substances of concern, and for other purposes.

Enacted

Public law number: P.L. 118-23

This bill’s path

271 days after it was introduced

This is H.R. 1734’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate5 months

  4. Resolving differences

  5. Sent to President

  6. Signed into law

Sponsor
Rep. Mike Collins (R-GA-10)
Cosponsors
25 cosponsors

18 original · 7 later

12 R · 13 D

  1. Rep. Brian Babin (R-TX-36)· Original · Mar 23, 2023
  2. Rep. Eric A. "Rick" Crawford (R-AR-1)· Original · Mar 23, 2023
  3. Rep. Yadira Caraveo (D-CO-8)· Original · Mar 23, 2023
  4. Rep. Valerie P. Foushee (D-NC-4)· Original · Mar 23, 2023
  5. Rep. Mike Garcia (R-CA-27)· Original · Mar 23, 2023
  6. Rep. Thomas H. Kean, Jr. (R-NJ-7)· Original · Mar 23, 2023
  7. Rep. Zoe Lofgren (D-CA-18)· Original · Mar 23, 2023
  8. Rep. Frank D. Lucas (R-OK-3)· Original · Mar 23, 2023
  9. Rep. Kevin Mullin (D-CA-15)· Original · Mar 23, 2023
  10. Rep. Jennifer L. McClellan (D-VA-4)· Original · Mar 23, 2023
  11. Rep. Jay Obernolte (R-CA-23)· Original · Mar 23, 2023
  12. Rep. Deborah K. Ross (D-NC-2)· Original · Mar 23, 2023
  13. Rep. Dale W. Strong (R-AL-5)· Original · Mar 23, 2023
  14. Rep. Eric Sorensen (D-IL-17)· Original · Mar 23, 2023
  15. Rep. Claudia Tenney (R-NY-24)· Original · Mar 23, 2023
  16. Rep. David J. Trone (D-MD-6)· Original · Mar 23, 2023
  17. Rep. Randy K. Weber, Sr. (R-TX-14)· Original · Mar 23, 2023
  18. Rep. Brandon Williams (R-NY-22)· Original · Mar 23, 2023
  19. Rep. Scott Franklin (R-FL-18)· Later · Mar 28, 2023
  20. Rep. Jeff Jackson (D-NC-14)· Later · Mar 28, 2023
  21. Rep. Max L. Miller (R-OH-7)· Later · Mar 28, 2023
  22. Rep. Haley M. Stevens (D-MI-11)· Later · Mar 30, 2023
  23. Rep. Emilia Strong Sykes (D-OH-13)· Later · Mar 30, 2023
  24. Rep. Summer L. Lee (D-PA-12)· Later · Apr 19, 2023
  25. Rep. Chris Pappas (D-NH-1)· Later · May 5, 2023
Policy area
Science, Technology, Communications
Subjects
  • Advanced technology and technological innovations
  • Chemistry
  • Congressional oversight
  • Drug trafficking and controlled substances
  • Higher education
  • Research administration and funding
  • Science and engineering education

On this page

Spending Breakdown

Funding provided

Identifiable budget authority. These categories are mutually exclusive; they are not added to authorizations or transfers.

Supplemental appropriations
$0
Advance appropriations
$0
Contract authority
$0

Funding authorized for later appropriation

Authorized for future appropriation and not already represented above as funding this law itself provides.

Authorization of appropriations
$0

Funding removed, moved, or limited

Rescissions reduce prior authority. Transfers move existing authority. Obligation limitations cap spending of contract authority; they are not new budget authority.

Rescissions
$0
Transfers
$0
Obligation limitations
$0

0 funding provisions identified.

Amounts are extracted from the enacted Statutes at Large text of this bill. They are a reading aid, not an official CBO score. Each figure remains traceable to the statutory section and source text. How to read the spending breakdown.

No funding provisions match this filter.

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

Jump to latest
1 amendment
  1. Jun 22, 2023 · S.Amdt. 139 · adopted
  1. Introduced in House

    Document: Introduced in House

    Sources
  2. ▸ 4 committee actions · Mar 23, 2023 – May 5, 2023
    1. Referred to committee

      Referred to the House Committee on Science, Space, and Technology.

      Sources
    2. Markup session held

      Committee Consideration and Mark-up Session Held.

      Sources
    3. Ordered reported

      Ordered to be Reported (Amended) by the Yeas and Nays: 36 - 0.

      Sources
    4. Reported by committee

      Reported (Amended) by the Committee on Science, Space, and Technology. H. Rept. 118-50.

      Sources
  3. Passed House

    Roll call 212

    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 425 - 0 (Roll no. 212). (text: 5/9/2023 CR H2149)

    The House passed the bill as amended.

    Document: Engrossed in House

    Sources
  4. S.Amdt. 139, adopted

    Major substitute

    Offered by Sen. Ted Cruz (R-TX)

    Amendment SA 139 agreed to in Senate by Unanimous Consent.

    in the nature of a substitute.

    Document: Engrossed Amendment Senate

    Sources
  5. Passed Senate

    Congressional Record S2250–S2251

    Passed Senate with an amendment by Unanimous Consent.

    The Senate passed the amended bill.

    Document: Engrossed Amendment Senate

    Sources
  6. House concurred in Senate amendment

    Congressional Record H6087–H6088

    On motion that the House suspend the rules and agree to the Senate amendment Agreed to by voice vote.

    The House concurred in the Senate amendment.

    Document: Enrolled Bill

    Sources
  7. Enrolled Bill

    Congress published an enrolled text of the bill.

    Document: Enrolled Bill

    Sources
  8. Presented to the President

    Presented to President.

    Sources
  9. Latest

    Law

    Signed by President

    Became Public Law 118–23.

    Document: Public Law

    Sources

Roll-call votes

  1. House roll call 212Passed

    On Motion to Suspend the Rules and Pass, as Amended

    425–0

Committees

  1. HouseScience, Space, and TechnologyReferred Mar 23, 2023 · Markup Mar 29, 2023 · Reported May 5, 2023H. Rept. 118-50
    1. Mar 29, 2023 · Markup

    1. H. Rept. 118-50 · May 5, 2023 · Testing, Rapid Analysis, and Narcotic Quality Research Act

Floor record

i

Explicit consideration evidence: the measure’s bill-status citation matched a GovInfo title, headline, or first paragraph. Incidental mentions are not listed.

  1. May 9, 2023 · House · Considered under suspension of the rulesCongressional Record H2149–H2151

    Testing, Rapid Analysis, and Narcotic Quality Research Act

  2. May 11, 2023 · House · Considered as unfinished businessCongressional Record H2295–H2296

    Testing, Rapid Analysis, and Narcotic Quality Research Act

  3. Jun 22, 2023 · Senate · Measure laid before Senate by unanimous consentCongressional Record S2250–S2251

    Testing, Rapid Analysis, and Narcotic Quality Research Act

  4. Dec 4, 2023 · House · Mr. Lucas moved that the House suspend the rules and agree to the Senate amendmentCongressional Record H6087–H6089

    Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Reported in House
Engrossed in House
Received in Senate
Engrossed Amendment Senate
Public Law
Enrolled Bill—
Titles (5)
  1. Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023

    Short title · Engrossed Amendment Senate, Enrolled Bill, Enacted, Passed Senate

  2. TRANQ Research Act of 2023

    Short title, Display title · Engrossed Amendment Senate, Enrolled Bill, Enacted, Passed Senate

  3. Testing, Rapid Analysis, and Narcotic Quality Research Act

    Short title · Introduced in House, Reported in House, Engrossed in House

  4. TRANQ Research Act

    Short title · Introduced in House, Reported in House, Engrossed in House

  5. To require coordinated National Institute of Standards and Technology science and research activities regarding illicit drugs containing xylazine, novel synthetic opioids, and other substances of concern, and for other purposes.

    Official title · Introduced in House